372 results on '"Ninomiya, Hironori"'
Search Results
2. Prognostic value of large amino acid transporter type 1 (LAT1) expression in pulmonary adenocarcinoma: A tissue microarray study
3. Distinct Prognostic Impact of PET Findings Based on Radiological Appearance in Clinical Stage IA Lung Adenocarcinoma
4. Positive bag lavage cytology during thoracoscopic surgery for lung cancer is a significant predictor of locoregional recurrence
5. Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma
6. Prognostic Stratification According to Size and Dominance of Radiologic Solid Component in Clinical Stage IA Lung Adenocarcinoma
7. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase–rearranged lung adenocarcinoma
8. A Reasonable Definition of Oligo-Recurrence in Non–Small-Cell Lung Cancer
9. Minimally invasive surgery for intradiaphragmatic bronchogenic cyst
10. Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy
11. Outcomes of nodal upstaging comparing video-assisted thoracoscopic surgery versus open thoracotomy for lung cancer
12. Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma
13. Utility of Maximum CT Value in Predicting the Invasiveness of Pure Ground-Glass Nodules
14. An Exploratory Study of Specimen Processing Methods for Successful Multiplex Genetic Analyses Using Lung Surgical Specimens
15. Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations
16. Ex-vivo 1.5T MR Imaging versus CT in Estimating the Size of the Pathologically Invasive Component of Lung Adenocarcinoma Spectrum Lesions
17. Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
18. Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients With Driver Mutations
19. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF
20. Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer
21. Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas
22. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non–Small-cell Lung Cancer
23. Focally Ossified Minimally Invasive Adenocarcinoma of the Lung Coexisting With Occult Pulmonary Metastases From Thyroid Cancer
24. Resurgence of morphology: Discarded small cell lung carcinoma subtypes reflect current molecular classification.
25. Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
26. Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by Machine Learning Models Based on Clinical and Radiological Features: Performance Comparison With Preoperative Biopsy
27. EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer
28. Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis
29. An extremely rare case of rapidly growing mediastinal well-differentiated liposarcoma with a sclerosing variant: a case report
30. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56
31. Ringlike Peripheral Increased Iodine Concentration for the Differentiation of Primary Lung Cancer and Pulmonary Metastases on Contrast-Enhanced Dual-Energy CT
32. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
33. Data from Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status
34. Supplemental materials and methods from Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status
35. FigureS1-S9, TableS1 from Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status
36. A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line
37. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene
38. High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild‐type epidermal growth‐factor receptor cases
39. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis
40. Combination of epidermal growth factor receptor mutation and the presence of high-grade patterns is associated with recurrence in resected stage I lung adenocarcinoma
41. Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation
42. Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations
43. Comparison of salvage surgeries for lung adenocarcinoma treated with anaplastic lymphoma kinase-tyrosine kinase inhibitors
44. Positive bag lavage cytology during thoracoscopic surgery for lung cancer is a significant predictor of locoregional recurrence
45. Standard therapy‑resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report
46. A reasonable definition of oligo-recurrence in non-small cell lung cancer
47. Pulmonary adenocarcinoma with mucin production and possible subtyping based on driver mutations and transcription factors
48. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
49. Correlation between morphology and EGFR mutations in lung adenocarcinomas: Significance of the micropapillary pattern and the hobnail cell type
50. Machine learning‐based gene alteration prediction model for primary lung cancer using cytologic images.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.